Hot Features
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologi... Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 7.69 | 24.838501292 | 30.96 | 38.8 | 30.19 | 213867 | 32.77672759 | CS |
| 4 | 9.85 | 34.2013888889 | 28.8 | 38.8 | 27.18 | 142286 | 30.81781622 | CS |
| 12 | 8.79 | 29.4373744139 | 29.86 | 38.8 | 26.3112 | 195494 | 29.23800648 | CS |
| 26 | 17.67 | 84.2230695901 | 20.98 | 38.8 | 16.77 | 284363 | 26.19916032 | CS |
| 52 | 18.52 | 92.001987084 | 20.13 | 38.8 | 14.385 | 351054 | 21.50459274 | CS |
| 156 | 21.75 | 128.698224852 | 16.9 | 61.07 | 13.7 | 264052 | 24.99488228 | CS |
| 260 | 21.75 | 128.698224852 | 16.9 | 61.07 | 13.7 | 264052 | 24.99488228 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.